Affiliation:
1. Quantitative Clinical Pharmacology; AstraZeneca LP; Waltham Massachusetts USA
Subject
Pharmacology (medical),Pharmacology
Reference10 articles.
1. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.;Panchal;Int. J. Clin. Pract.,2007
2. Novel opioid antagonists for opioid-induced bowel dysfunction.;Diego;Expert. Opin. Investig. Drugs,2011
3. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation.;Webster;Pain,2013
4. Movantik™ (naloxegol) Full Prescribing Information. AstraZeneca Pharmaceuticals LP, Wilmington, DE 2014
5. Moventig® (naloxegol) Full Prescribing Information. AstraZeneca AB, Södertälje, Sweden 2014
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献